NeurologyLive® Friday 5 — October 2, 2026

Welcome to NeurologyLive^®'s Friday 5! Every week, the staff compiles 5 highlights of NeurologyLive's widespread coverage in neurology, ranging from newsworthy study findings and FDA action to expert interviews and peer-to-peer panel discussions.

Don’t have time to read or watch a full video interview? Click here to check out our shorts!

Click the read more or watch now buttons for more details and information about each highlight.

1: Moving the Needle on Stroke Recurrence in Patients With Limited Access to Care: Eva Mistry, MD

In a recent video interview, Eva Mistry, MD, professor of neurology at the University of Cincinnati, discussed how clinical awareness of social determinants and expanded telehealth have begun to move the needle for stroke care. [WATCH TIME: 7 minutes]

2: Cognitive Dysfunction in MS: Rethinking Assessment and Management

In a new “MS Compass: Guiding Clinical Care” podcast episode, host Lindsay Ross, MD, is joined by joined by Rachel Galioto, PhD, a Cleveland Clinic neuropsychologist focused on neuroimmunology, to explore how clinicians can better recognize, assess, and manage cognitive concerns in patients with multiple sclerosis. [LISTEN TIME: 33 minutes]

3: Gray Areas: Realistic Possibility of Reversing Diabetic Neuropathy

A new episode our “Gray Areas” show features a conversation with Brian Callaghan, MD, MS, professor of neurology at the University of Michigan, discussing the clinical debate around whether diabetic peripheral neuropathy is reversible if diagnosed and treated early enough. [WATCH TIME: 7 minutes]

4: NeuroVoices: James Winkley, MD, on Analyzing Phase 3 PREVAIL Trial of Gefurulimab

In our latest NeuroVoices Q&A, James Winkley, MD, chairman of the Neurology Service Line at Baptist Health in Kentucky, discussed PREVIEW trial findings for gefelorilimab in generalized myasthenia gravis, including efficacy, safety, and what the subcutaneous C5 inhibitor could offer patients if approved.

5: Episode 176: BBP-418 and the Changing Treatment Landscape of LGMD

In a special episode of Mind Moments, released in recognition of Limb-Girdle Muscular Dystrophy (LGMD) Awareness Day, Katherine Mathews, MD, professor of pediatrics and neurology at the University of Iowa Carver College of Medicine, joins the podcast to discuss the evolving treatment landscape for LGMD and the potential significance of BBP-418, an investigational oral therapy for LGMD2I/R9. [LISTEN TIME: 17 minutes]